ask="0.99"
ask_size="500"
average_daily_volume="336782"
bid="0.60"
bid_size="200"
book_value="0.12"
change="+0.00"
change_from_200_day_moving_average="-0.30"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-2.06"
change_From_52_week_low="0.50"
change_in_percent="+0.01%"
close="0.99"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.83"
ebitda="-21.56M"
eps_estimate_current_year="-0.81"
eps_estimate_next_quarter="-0.18"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="19095000"
high="0.99"
high_52_weeks="3.05"
last_trade_date="1/26/2017"
last_trade_price="0.99"
last_trade_size="500"
last_trade_time="3:58pm"
low="0.96"
low_52_weeks="0.49"
market_capitalization="29.10M"
moving_average_200_day="1.29"
moving_average_50_day="1.00"
name="Galectin Therapeutics Inc."
notes="N/A"
one_year_target_price="1.12"
open="0.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-23.53%"
percent_change_from_50_day_moving_average="-0.97%"
percent_change_from_52_week_high="-67.54%"
percent_change_from_52_week_low="+102.04%"
previous_close="0.99"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.92"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="29396000"
short_ratio="4.22"
stock_exchange="NCM"
symbol="GALT"
volume="90442"
weeks_range_52="0.49 - 3.05"
